Home |
Free Dividend Report |
Stock Splits Calendar |
ASTX Historical Stock Prices |
Preferred Stock Newsletter |
ASTX Options Chain |
ASTX Message Board |
ASTX (ASTX) has the following price history information. Looking back at ASTX historical stock prices for the last five trading days, on October 07, 2013, ASTX opened at $8.51, traded as high as $8.56 and as low as $8.49, and closed at $8.52. Trading volume was a total of 3.30M shares. On October 08, 2013, ASTX opened at $8.50, traded as high as $8.51 and as low as $8.48, and closed at $8.48. Trading volume was a total of 2.88M shares. On October 09, 2013, ASTX opened at $8.50, traded as high as $8.50 and as low as $8.48, and closed at $8.49. Trading volume was a total of 2.39M shares. On October 10, 2013, ASTX opened at $8.51, traded as high as $8.51 and as low as $8.48, and closed at $8.49. Trading volume was a total of 1.72M shares. On October 11, 2013, ASTX opened at $8.50, traded as high as $8.50 and as low as $8.50, and closed at $8.50. Trading volume was a total of 0 shares.
ASTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ASTX shares, starting with a $10,000 purchase of ASTX, and working forward through the historical stock price information to today. ASTX -- use the split history when considering split-adjusted past price performance.
ASTX Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
10/07/2013 | $8.51 | $8.56 | $8.49 | $8.52 | 3.30M |
10/08/2013 | $8.50 | $8.51 | $8.48 | $8.48 | 2.88M |
10/09/2013 | $8.50 | $8.50 | $8.48 | $8.49 | 2.39M |
10/10/2013 | $8.51 | $8.51 | $8.48 | $8.49 | 1.72M |
10/11/2013 | $8.50 | $8.50 | $8.50 | $8.50 | 0 |
About ASTX |
Astex Pharmaceuticals is engaged in the discovery and development of small molecule therapeutics with a focus on oncology and hematology. Co. sells Dacogen®, a product approved by the U.S. FDA for the treatment of myelodysplastic syndromes, and approved by the European Commission for the treatment of adult patients with newly diagnosed de novo or secondary acute myeloid leukemia who are not candidates for standard induction chemotherapy. At Dec 31 2012, Dacogen was approved for sale in 35 additional countries outside of the U.S. and Europe. Also, Co.'s Astex Therapeutics Limited subsidiary has a pipeline of drugs at various stages of clinical, pre-clinical, and early discovery development. |
ASTX Historical Closing Prices | |
Date | Close |
10/07/2013 | $8.52 |
10/08/2013 | $8.48 |
10/09/2013 | $8.49 |
10/10/2013 | $8.49 |
10/11/2013 | $8.50 |
Healthcare Historical Prices |
ASTX is categorized under the Healthcare sector; below are some other companies in the same sector:
ATEC Historical Stock Prices
Free ASTX Email Alerts:
|
ASTX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.